学术探索
学术期刊
新闻热点
数据分析
智能评审

Targeting VEGF in cancer therapy

被引：26
作者：
不详
机构：
来源：
CURRENT PROBLEMS IN CANCER | 2006年 / 30卷 / 01期
关键词：
D O I：
10.1016/j.currproblcancer.2005.11.001
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：7 / 32
页数：26
相关论文
共 99 条
[51]  
Koukourakis MI, 2000, CANCER RES, V60, P3088
[52]  
LEE D, 2005, ONCOL BRIEF, V3, P1
[53]   Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients [J].
Lee, JC ;
Chow, NH ;
Wang, ST ;
Huang, SM .
EUROPEAN JOURNAL OF CANCER, 2000, 36 (06) :748-753
[54]  
LEVINE A, 2004, P AN M AM SOC CLIN, pA3008
[55]  
MARTINELLI E, 2005, P AN M AM SOC CLIN, pA3039
[56]   The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis [J].
Maxwell, PH ;
Wiesener, MS ;
Chang, GW ;
Clifford, SC ;
Vaux, EC ;
Cockman, ME ;
Wykoff, CC ;
Pugh, CW ;
Maher, ER ;
Ratcliffe, PJ .
NATURE, 1999, 399 (6733) :271-275
[57]  
Mendel DB, 2003, CLIN CANCER RES, V9, P327
[58]   A Multicenter phase II trial of ZD6474, a vascular endothelial growth factor receptor-2 and epidermal growth factor receptor tyrosine kinase inhibitor, in patients with previously treated metastatic breast cancer [J].
Miller, KD ;
Trigo, JM ;
Wheeler, C ;
Barge, A ;
Rowbottom, J ;
Sledge, G ;
Baselga, J .
CLINICAL CANCER RESEARCH, 2005, 11 (09) :3369-3376
[59]  
Miller KD, 2002, BREAST CANCER RES TR, V76, pS37
[60]   Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer and liver metastases:: Results from two phase I studies [J].
Morgan, B ;
Thomas, AL ;
Drevs, J ;
Hennig, J ;
Buchert, M ;
Jivan, A ;
Horsfield, MA ;
Mross, K ;
Ball, HA ;
Lee, L ;
Mietlowski, W ;
Fuxius, S ;
Unger, C ;
O'Byrne, K ;
Henry, A ;
Cherryman, GR ;
Laurent, D ;
Dugan, M ;
Marmé, D ;
Steward, WP .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (21) :3955-3964
12345678910